OxCKD1 -Empowering Healthy Lifestyle Choices in Chronic Kidney Disease
OxCKD1
OxCKD1 - a Randomised Controlled Trial of the OxSalt1 Care Bundle to Help Renal Patients Learn How to Lower the Salt Content of Their Diets.
1 other identifier
interventional
201
1 country
1
Brief Summary
Patients with kidney disease benefit from reducing the amount of salt in the food that they eat. The benefits include lower blood pressure and better kidney function. Therefore, lowering the amount of salt that is eaten could reduce the number of people who will develop kidney failure. The effect on blood pressure could also reduce the number of strokes and heart attacks. Similar benefits are also seen for people without kidney disease. Guidelines for patients with kidney disease recommend that they lower the amount of salt that they eat, but most patients do not manage to do this. The reasons for this are not unclear, but are likely to reflect the difficulty that patients have in reducing the amount of salt in their food and the nature of the advice that they are given. The investigators have developed a package of interventions to help patients to make healthier choices that will lower their salt intake. The package helps patients to learn about salt in food and how to avoid it. It provide practical advice on cutting down on salt using information booklets, text messages, emails, telephone calls, and a website. Participants will be recruited from hospital kidney clinics and general practice. The investigators will randomly allocate participants to receive either the normal care that they would get or to receive the new package of interventions to help them lower salt. The package of interventions will involve patients receiving text messages, telephone calls, emails and written information. They will complete a questionnaire and collect urine samples which will can be used to measure the amount of salt that they are eating. No more than 6 visits will be required. The study is funded by the British Renal Society which is a charity that funds research to help patients with kidney disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2012
CompletedFirst Posted
Study publicly available on registry
March 13, 2012
CompletedStudy Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedResults Posted
Study results publicly available
August 19, 2024
CompletedAugust 19, 2024
December 1, 2014
2.6 years
March 1, 2012
September 7, 2023
March 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
24-hour Urinary Sodium Excretion
To evaluate whether a new care bundle helps patients to reduce their salt intake.
1 month
24-hour Urinary Salt Excretion
1 month
Secondary Outcomes (4)
24-hour Urinary Sodium Excretion
3 months
24-hour Urinary Salt Excretion
3 months
24-hour Urinary Sodium Excretion
11 months
24-hour Urinary Salt Excretion
11 months
Study Arms (2)
Intervention
EXPERIMENTALA package of advice and interventions to help participants reduce their salt intake.
Normal care
NO INTERVENTIONThis group will receive the normal care that they would get anyway.
Interventions
A care bundle consisting of a range of features to help patients to reduce their salt intake such as reminder emails, phone calls and a website.
Eligibility Criteria
You may qualify if:
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Diagnosed with CKD and an eGFR ≥ 20 ml/min/1.73m2
- Participant has clinically acceptable laboratory data available to confirm the diagnosis.
- Able (in the opinion of the Investigators) and willing to comply with all study requirements.
- Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study
You may not qualify if:
- Female participants who is pregnant, lactating or planning pregnancy during the course of the study.
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
- Inability to understand English or special communication needs because the interventions will use English and is not funded to deal with special communication needs.
- Known salt losing nephropathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oxfordlead
- British Renal Societycollaborator
Study Sites (1)
Oxford University Hospitals NHS Trust
Oxford, Oxfordshire, OX3 7LE, United Kingdom
Related Publications (2)
O'Callaghan CA, Camidge C, Thomas R, Reschen ME, Maycock AJ, Lasserson DS, Fox RA, Thomas NPB, Shine B, James T. Evaluation of a Simple Low-cost Intervention to Empower People with CKD to Reduce Their Dietary Salt Intake: OxCKD1, a Multicenter Randomized Controlled Trial. Kidney360. 2023 Jul 1;4(7):890-898. doi: 10.34067/KID.0000000000000160. Epub 2023 May 31.
PMID: 37254243DERIVEDMcMahon EJ, Campbell KL, Bauer JD, Mudge DW, Kelly JT. Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev. 2021 Jun 24;6(6):CD010070. doi: 10.1002/14651858.CD010070.pub3.
PMID: 34164803DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Principal Investigator
- Organization
- University of Oxford
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher A O'Callaghan, MD PhD
University of Oxford, UK
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2012
First Posted
March 13, 2012
Study Start
April 1, 2012
Primary Completion
November 1, 2014
Study Completion
November 1, 2014
Last Updated
August 19, 2024
Results First Posted
August 19, 2024
Record last verified: 2014-12